跳至主要内容
临床试验/JPRN-UMIN000003528
JPRN-UMIN000003528已完成未知

The efficacy and safety of Kampo (Japanese herbal) medicine, bofutsushosan, on matabolic syndrome -a randomized, double-blind, placebo-controlled trial- - The efficacy and safety of bofutsushosan on matabolic syndrome

Oriental Medicine Research Center, Kitasato University0 个研究点目标入组 180 人开始时间: 2010年4月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.those who are taking Kampo drugs 2.those who have taken Kampo drugs in the past 4 weeks 3.those who need the treatment by conventional medicine 4.those who present significant liver or renal dysfunction 5.those who are taking the drugs affecting abdominal circumference or body weight 6.those who are taking antihyperlipidemic agents, antihypertensive agents, or antihyperglycemic agents 7.those with malignancy or heart failure which affects their general condition 8.those judged unsuitable for the trial by physician-in-charge

研究者

发起方
Oriental Medicine Research Center, Kitasato University

相似试验

The efficacy and safety of Kampo (Japanese herbal)... | 临床试验